EXAS - Exact Sciences down 17% on quarterly bottom line miss maintaining 2024 guidance
2024-05-08 17:28:07 ET
More on Exact Sciences
- Exact Sciences: Cancer Battle Continues, Shares Likely To Plateau
- Exact Sciences Corporation (EXAS) Q4 2023 Earnings Call Transcript
- Exact Sciences Corporation 2023 Q4 - Results - Earnings Call Presentation
- Exact Sciences Q1 2024 Earnings Preview
- Exact Sciences names Aaron Bloomer as CFO